Revenue of Intellia Therapeutics 2015-2023
The collaboration revenue of Intellia therapeutics in 2023 was 36.3 million U.S. dollars. Intellia Therapeutics is a U.S.-based biotech company focusing on the development of therapeutics using CRISPR technology.